SEMINAR: COMPREHENSIVE TREATMENT APPROACHES IN THE MANAGEMENT OF ROSACEA

Friday, July 13, 2018 | 7:00pm–8:00pm
Omni Grove Park Inn | Asheville, NC

Marc Darst, MD

Guest Speaker: Marc A. Darst, MD*
Darst Dermatology, PC, Charlotte, NC

The speaker has received compensation from Galderma Laboratories, L.P., the maker of SOOLANTRA® (ivermectin) Cream, 1%, in conjunction with this speaking event. Meeting participants will not receive compensation.

**IMPORTANT SAFETY INFORMATION**
**Indication:** SOOLANTRA® (ivermectin) Cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use.
**Adverse Events:** In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit [WWW.FDA.GOV/MEDWATCH](http://WWW.FDA.GOV/MEDWATCH) or call 1-800-FDA-1088.
© 2018 Galderma Laboratories, L.P. All rights reserved.
All trademarks are the property of their respective owners.
This session does not offer CME credit.